Techno Trends
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
Biogen and Sage Therapeutics Introduce First-of-its-Kind ZURZUVAE™ for Postpartum Depression
Biogen has introduced first-of-its-kind ZURZUVAE™ (zuranolone) approved for adults with postpartum depression (PPD). This new treatment seems to be a significant step forward in addressing the needs of women who suffer from this condition....
Jacobio Pharma Introduces Novel KRAS G12C Inhibitor Glecirasib for Pancreatic Cancer
Jacobio Pharma has introduced an innovative in-house solution with the KRAS G12C inhibitor, Glecirasib, aimed at treating patients with pancreatic cancer....
NS Pharma Develops First-of-its-Kind NS-089 NCNP-02 for Duchenne Muscular Dystrophy
NS Pharma has developed first-of-its-kind NS089/NCNP-02, an investigational candidate for individuals diagnosed with Duchenne muscular dystrophy (DMD) who could potentially benefit from exon 44 skipping therapy....
Evogene Developed Breakthrough ChemPass AI Tech-Engine for Target-Protein Discovery
Evogene has recently unveiled the revolutionary ChemPass AI Tech-Engine, featuring cutting-edge machine learning technology tailored for target-protein discovery....
Janssen's Novel Bispecific Antibodies TALVEY® (talquetamab) and TECVAYLI® (teclistamab) Shows Positive CHMP Opinions for Refractory Multiple Myeloma Treatment
Janssen has received positive opinions for two novel talquetamab and teclistamab bispecific antibodies for the trreatment of patients with Relapsed and Refractory Multiple Myeloma....
Huntsman Cancer Institute at the University of Utah Develops Novel Prostate Cancer Therapy
Enzalutamide is a medication commonly used for prostate cancer treatment, but the addition of talazoparib is a novel approach specifically for patients with prostate cancer....
Skyline Therapeutics Develops SKG0106, a Novel Gene Therapy Candidate
Skyline Therapeutics developed SKG0106, a novel intravitreally delivered AAV gene therapy targeting neovascular age-related macular degeneration (nAMD)....
HUTCHMED Introduces Novel Fruquintinib in Combination with Sintilimab for Advanced Endometrial Cancer
The combination of fruquintinib and sintilimab is a promising development for patients with advanced endometrial cancer with pMMR1 tumours who have failed at least one line of platinum-based therapy....
Renibus Therapeutics Introduced First-of-its-Kind RBT-1 for Reducing Post-Operative Complications
Renibus Therapeutics has introduced first-of-its-kind RBT-1 to reduce the risk of post-operative complications in patients undergoing cardiothoracic surgery....
Ascentage Pharma Developed Novel Olverembatinib Drug Candidate to Treat SDH-Deficient GIST
Ascentage Pharma developed olverembatinib (HQP1351), novel drug candidate, for the treatment of patients with succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumour (GIST) who had obtained first-line treatment....
